Article Information
PubMed
Published By
Print ISSN
Online ISSN
History
- Published online April 15, 2012.
Article Versions
- You are currently viewing a Latest version of this article (April 15, 2012 - 04:00).
- View the most recent version of this article
Copyright & Usage
© 2011 The Journal of Rheumatology
Author Information
- Laure Thomas,
- Florence Canoui-Poitrine,
- Jacques-Eric Gottenberg,
- Andra Economu-Dubosc,
- Fatiha Medkour,
- Xavier Chevalier,
- Sylvie Bastuji-Garin,
- Hervé Le Louët,
- Valérie Farrenq and
- Pascal Claudepierre
- From the Pharmacovigilance Center, Chenevier-Mondor Hospital, AP-HP, Créteil; Université Paris Est Créteil, EA4393 Laboratoire d’Investigation Clinique, Créteil; Department of Clinical Research and Public Health, Hôpital Henri-Mondor, AP-HP, Créteil; Service de Rhumatologie, Hôpitaux Universitaires de Strasbourg, EA 4438, Physiopathologie des Arthrites, Université de Strasbourg, Strasbourg; and Department of Rheumatology, Chenevier-Mondor Hospital, AP-HP, Créteil, France.
Dr. Bastuji-Garin has received lecture fees from AstraZeneca. Dr. Gottenberg has received consulting fees, speaking fees, and/or honoraria from Abbott, Wyeth-Pfizer, Roche, Chugai, Bristol-Myers Squibb, Schering-Plough, and UCB (less than $10,000 each). Dr. Chevalier has received consulting fees, speaking fees, and/or honoraria from Servier, MSD, Genevrier, and Expanscience (less than $10,000 each). Prof. Claudepierre has received consulting fees, speaking fees, and/or honoraria from Abbott, Wyeth-Pfizer, Roche, Chugai, Bristol-Myers Squibb, Schering-Plough, and UCB (less than $10,000 each), and was an investigator for Roche Chugai, Sanofi Aventis, Abbott, Wyeth-Pfizer, and BMS.
L. Thomas, MD, Pharmacovigilance Center, Chenevier-Mondor Hospital, AP-HP; F. Canoui-Poitrine, MD, PhD, Université Paris Est Créteil, EA4393, Laboratoire d’Investigation Clinique; Department of Clinical Research and Public Health, Hôpital Henri-Mondor, AP-HP; J-E. Gottenberg, MD, PhD, Service de Rhumatologie, Hôpitaux Universitaires de Strasbourg, EA 4438, Physiopathologie des Arthrites, Université de Strasbourg; A. Economu-Dubosc, MD; F. Medkour, MD, Pharmacovigilance Center, Chenevier-Mondor Hospital, AP-HP; X. Chevalier, MD, PhD, Department of Rheumatology, Chenevier-Mondor Hospital, AP-HP; S. Bastuji-Garin, MD, PhD, Université Paris Est Créteil, EA4393 Laboratoire d’Investigation Clinique; Department of Clinical Research and Public Health, Hôpital Henri-Mondor, AP-HP; H. Le-Louët, MD, PhD, Pharmacovigilance Center, Chenevier-Mondor Hospital, AP-HP; V. Farrenq, MD, Department of Rheumatology, Chenevier-Mondor Hospital, AP-HP; P. Claudepierre, MD, Department of Rheumatology, Chenevier-Mondor Hospital, AP-HP; Université Paris Est Créteil, EA4393 Laboratoire d’Investigation Clinique.
Address correspondence to Prof. P. Claudepierre, Service de Rhumatologie, Hôpital Henri Mondor, 51 Avenue Maréchal de Lattre de Tassigny, 94010 Creteil, France. E-mail: pascal.claudepierre@hmn.aphp.fr
Accepted for publication January 13, 2012.